EXCLUSIVE LICENSING AGREEMENT FOR IN-HOUSE DEVELOPED MONOCLONAL ANTIBODY FARLETUZUMAB IN LATIN AMERICA CONCLUDED WITH EUROFARMA LABORATÓRIOS S.A.
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.eisai.com/news/pdf/enews201672pdf.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
